
Allovir, Inc. (ALVR) Earnings Dates & Reports
Allovir, Inc. (ALVR) Most Recent Earnings
Report DateAug 8, 2024
Period EndingQ2 2024
Est. EPS-$2.07
Actual EPS-$1.15
EarningsBeat
Allovir, Inc. (ALVR) Earnings
View the latest Allovir, Inc. (ALVR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Allovir, Inc. (ALVR)
Order type
Buy in
Order amount
Est. shares
0 shares
Allovir, Inc. (ALVR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Allovir, Inc. (ALVR) Latest Earnings
The value each ALVR share was expected to gain vs. the value each share gained.
Allovir, Inc. (ALVR) reported its most recent earnings on Aug 8, 2024 for Q2 2024, posting earnings per share (EPS) of -$1.15. This exceeded analysts' expectations of -$2.07 by 44.44%, marking a Beat.
For comparison, Allovir, Inc. reported EPS of -$11.04 in the same quarter last year.
The company is expected to announce its next earnings report on 08/09/2024, with analysts projecting an EPS of $0.
Allovir, Inc. (ALVR) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2024Aug 8, 2024 | -$2.07 | -$1.15 | -44.44% | |
Q1 2024May 13, 2024 | -$4.14 | -$5.98 | +44.44% | |
Q4 2023Mar 15, 2024 | -$9.89 | -$12.19 | +23.26% | |
Q3 2023Nov 2, 2023 | -$9.66 | -$8.97 | -7.14% | |
Q2 2023Aug 3, 2023 | -$10.12 | -$11.04 | +9.09% | |
Allovir, Inc. (ALVR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Allovir, Inc.’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 13, 2024 | — | — | — |
Mar 15, 2024 | — | — | — |
Nov 2, 2023 | — | — | — |
Aug 3, 2023 | — | — | — |
Allovir, Inc. (ALVR) Earnings FAQs
Allovir, Inc. (ALVR) last reported earnings on Aug 8, 2024 for Q2 2024, posting an EPS of -$1.15, which Beat the estimate of -$2.07 by 44.44%.
For Q2 2024, Allovir, Inc. (ALVR) reported an EPS of -$1.15, exceeding analysts' estimate of -$2.07 by 44.44%.
For Q2 2024, Allovir, Inc. (ALVR) Beat expectations with an actual EPS of -$1.15 vs. an estimated EPS of -$2.07.
Following the last earnings report on Aug 8, 2024, Allovir, Inc. (ALVR)'s stock price moved — from — to —.
The next Allovir, Inc. (ALVR) earnings call is scheduled for Aug. 9, 2024, where executives will discuss financial results and outlook.